LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 13.78 | 771.67 | 1373 | 1459 | 0.9406 | 0.8711 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.00 | 771.67 | 1328 | 1585 | 0.8376 | 0.6863 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.00 | 771.67 | 1428 | 1585 | 0.9007 | 0.8084 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.22 | 771.67 | 1406 | 1741 | 0.8074 | 0.6669 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.22 | 771.67 | 1560 | 1741 | 0.8958 | 0.8212 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 20.44 | 771.67 | 1468 | 1910 | 0.7682 | 0.6349 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 20.44 | 771.67 | 1664 | 1910 | 0.8708 | 0.7993 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 22.66 | 771.67 | 1580 | 2141 | 0.7378 | 0.6269 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 22.66 | 771.67 | 1770 | 2141 | 0.8265 | 0.7573 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.89 | 771.67 | 1701 | 2397 | 0.7094 | 0.6213 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.89 | 771.67 | 1911 | 2397 | 0.7970 | 0.7409 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.11 | 771.67 | 1847 | 2675 | 0.6904 | 0.6268 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.11 | 771.67 | 2071 | 2675 | 0.7742 | 0.7340 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.33 | 771.67 | 1986 | 2939 | 0.6757 | 0.6322 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.33 | 771.67 | 2222 | 2939 | 0.7559 | 0.7300 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 31.55 | 771.67 | 2120 | 3196 | 0.6632 | 0.6370 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 31.55 | 771.67 | 2405 | 3196 | 0.7523 | 0.7408 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 33.78 | 771.67 | 2272 | 3499 | 0.6492 | 0.6406 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 33.78 | 771.67 | 2559 | 3499 | 0.7312 | 0.7326 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.00 | 771.67 | 2451 | 3884 | 0.6309 | 0.6415 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.00 | 771.67 | 2663 | 3884 | 0.6855 | 0.7010 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 38.22 | 771.67 | 2630 | 4299 | 0.6117 | 0.6402 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 38.22 | 771.67 | 2867 | 4299 | 0.6668 | 0.6983 | MN20160304_L01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 40.44 | 771.67 | 2827 | 4738 | 0.5966 | 0.6420 | MN20160304_L01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 40.44 | 771.67 | 3115 | 4738 | 0.6574 | 0.7039 | MN20160304_L01 | M06 |